Salvianolic acid B, for instance, inhibits glycolysis by targeting GJB2 and induces apoptosis in HCC, while simultaneously improving the efficacy of anti-PD-1 therapy by reducing T cell exhaustion25. The gene discussed is GJB2; the disease is hepatocellular carcinoma.